The Institute for Protein Design will become an innovation hub for new therapeutics for a variety of common, serious diseases. It will also engineer new nanomaterials for industry.
Scientists at UW Medicine’s Institute for Protein Design have created a new protein that mimics the action of a key immune regulatory protein, interleukin 2 (IL-2). IL-2 is a potent anticanc
Protein assemblies, designed and built from scratch to carry molecular cargo, are advancing both synthetic life research and engineering efforts for targeted drug delivery.
These computer-designed proteins, which did not previously exist in nature, combine the stability and bioavailability of small molecule drugs with the specificity and potency of larger biologics. They would not require refrigeration, and they l
A collaboration involving UW Medicine researchers reached a major milestone toward helping investigators create drug therapies and vaccines for some of the world’s major infectious diseases.
